Your browser doesn't support javascript.
loading
Assessing the incidence and severity of drug adverse events: a Bayesian hierarchical cumulative logit model.
Duan, Jiawei; Gajewski, Byron J; Sen, Paramita; Wick, Jo A.
Affiliation
  • Duan J; Global Drug Development, Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, New Jersey, USA.
  • Gajewski BJ; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas, USA.
  • Sen P; Global Drug Development, Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, New Jersey, USA.
  • Wick JA; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas, USA.
J Biopharm Stat ; 34(2): 276-295, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37016726
ABSTRACT
Detection of safety signals based on multiple comparisons of adverse events (AEs) between two treatments in a clinical trial involves evaluations requiring multiplicity adjustment. A Bayesian hierarchical mixture model is a good solution to this problem as it borrows information across AEs within the same System Organ Class (SOC) and modulates extremes due merely to chance. However, the hierarchical model compares only the incidence rates of AEs, regardless of severity. In this article, we propose a three-level Bayesian hierarchical non-proportional odds cumulative logit model. Our model allows for testing the equality of incidence rate and severity for AEs between the control arm and the treatment arm while addressing multiplicities. We conduct simulation study to investigate the operating characteristics of the proposed hierarchical model. The simulation study demonstrates that the proposed method could be implemented as an extension of the Bayesian hierarchical mixture model in detecting AEs with elevated incidence rate and/or elevated severity. To illustrate, we apply our proposed method using the safety data from a phase III, two-arm randomized trial.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Logistic Models Type of study: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Biopharm Stat Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Logistic Models Type of study: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Biopharm Stat Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos